nach oben

01.06.2002 | Review

Genetic epidemiology: Psoriatic arthritis

Erschienen in: Arthritis Research & Therapy | Ausgabe 4/2002

Einloggen, um Zugang zu erhalten

Abstract

The existence of psoriatic arthritis as a distinct clinical entity remains a topic of debate; some authors propose that it is simply the co-occurrence of psoriasis and inflammatory arthritis. However, a distinct entity is likely to have distinct susceptibility factors in addition to those that contribute to psoriasis and inflammatory arthritis alone. These aetiological factors may be genetic and/or environmental, and in this review, the evidence for distinct psoriatic arthritis genetic susceptibility factors is considered.

Moll JMH, Wright V: Psoriatic arthritis. Semin Arthritis Rheum. 1973, 3: 55-78. 10.1016/0049-0172(73)90035-8.PubMedCrossRef

Cats A: Psoriasis and arthritis. Cutis. 1990, 46: 323-329.PubMed

Kay LJ, Parry-James JE, Walker DJ: The prevalence and impact of psoriasis and psoriatic arthritis in the primary care population in North East England [abstract]. Arthritis Rheum. 1999, 42: s299-10.1002/1529-0131(199902)42:2<299::AID-ANR12>3.0.CO;2-R.CrossRef

Harrison BJ, Silman AJ, Barrett EM, Scott DGI, Symmons DPM: Presence of psoriasis does not influence the presentation or short-term outcome of patients with early inflammatory polyarthritis. J Rheumatol. 1997, 24: 1744-1747.PubMed

Hellgren L: Association between rheumatoid arthritis and pso-riasis in total populations. Acta Rheumatol Scand. 1969, 15: 316-326.PubMedCrossRef

Baker H: Prevalence of psoriasis in polyarthritic patients and their relatives. Ann Rheum Dis. 1966, 25: 229-234.PubMedPubMedCentralCrossRef

McGonagle D, Conaghan PG, Emery P: Psoriatic arthritis: a unified concept twenty years on. Arthritis Rheum. 1999, 42: 1080-1086. 10.1002/1529-0131(199906)42:6<1080::AID-ANR2>3.0.CO;2-7.PubMedCrossRef

Gladman DD: Psoriatic arthritis. In Ballieres Clinical Rheumatology. Classification and assessment of rheumatic disease: Part 1. Edited by: Silman AJ, Symmons DPM. 1995, London: Balliere Tindall, 319-329.

Fournie B, Crognier L, Arnaud C, Zabraniecki L, Lascaux-Lefebvre V, Marc V, Ginesty E, Andrieu V, Dromer C, Fournie A: Proposed classification criteria of psoriatic arthritis: a preliminary study in 260 patients. Rev Rhum Engl Ed. 1999, 66: 446-456.PubMed

10.

Barton AC, Bruce IN, Silman AJ: Genetic studies of psoriatic arthritis: dissecting joints and skin. J Rheumatol. 2001, 28: 3-5.PubMed

11.

Bruce IN, Silman AJ: The aetiology of psoriatic arthritis. Rheumatology. 2001, 40: 363-366. 10.1093/rheumatology/40.4.363.PubMedCrossRef

12.

Vyse TJ, Todd JA: Genetic analysis of autoimmune disease. Cell. 1996, 85: 311-318.PubMedCrossRef

13.

Nair RP, Henseler T, Jenisch S, Stuart P, Bichakjian CK, Lenk W, Westphal E, Guo SW, Christophers E, Voorhees JJ, Elder JT: Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel regions (16q and 20p) by genome-wide scan. Hum Mol Genet. 1997, 6: 1349-1356. 10.1093/hmg/6.8.1349.PubMedCrossRef

14.

Trembath RC, Clough RL, Rosbotham JL, Jones AB, Camp RD, Frodsham A, Browne J, Barber R, Terwilliger J, Lathrop GM, Barker JN: Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by two stage genome-wide search in psoriasis. Hum Mol Genet. 1997, 6: 813-820. 10.1093/hmg/6.5.813.PubMedCrossRef

15.

Burden AD, Javed S, Bailey M, Hodgins M, Connor M, Tillman D: Genetics of psoriasis: paternal inheritance and a locus on chromosome 6p. J Invest Dermatol. 1998, 110: 958-960. 10.1046/j.1523-1747.1998.00213.x.PubMedCrossRef

16.

Capon F, Novelli G, Semprini S, Clementi M, Nudo M, Vultaggio P, Mazzanti C, Gobello T, Botta A, Fabrizi G, Dallapiccola B: Searching for psoriasis susceptibility genes in Italy: genome-scan and evidence for a new locus on chromosome 1. J Invest Dermatol. 1999, 112: 32-35. 10.1046/j.1523-1747.1999.00471.x.PubMedCrossRef

17.

Balendran N, Clough RL, Arguello JR, Barber R, Veal C, Jones AB, Rosbotham JL, Little AM, Madrigal A, Barker JN, Powis SH, Trembath RC: Characterization of the major susceptibility region for psoriasis at chromosome 6p21.3. J Invest Dermatol. 1999, 113: 322-328. 10.1046/j.1523-1747.1999.00710.x.PubMedCrossRef

18.

Samuelsson L, Enlund F, Torinsson A, Yhr M, Inerot A, Enerback C, Wahlstrom J, Swanbeck G, Martinsson T: A genome-wide search for genes predisposing to familial psoriasis by using a stratification approach. Hum Genet. 1999, 105: 523-529. 10.1007/s004390051141.PubMedCrossRef

19.

Lee YA, Ruschendorf F, Windemuth C, Schmitt-Egenolf M, Stadelmann A, Nurnberg G, Stander M, Wienker TF, Reis A, Traupe H: Genomewide scan in German families reveals evidence for a novel psoriasis-susceptibility locus on chromosome 19p13. Am J Hum Genet. 2000, 67: 1020-1024. 10.1086/303075.PubMedPubMedCentralCrossRef

20.

Enerback C, Martinsson T, Inerot A, Wahlstrom J, Enlund F, Yhr M, Swanbeck G: Evidence that HLA-Cw6 determines early onset of psoriasis, obtained using sequence-specific primers (PCR-SSP). Acta Derm Venereol. 1997, 77: 273-276.PubMed

21.

Nair RP, Stuart P, Henseler T, Jenisch S, Chia NVC, Westphal E, Schork NJ, Kim J, Lim HW, Christophers E, Voorhees JJ, Elder JT: Localization of psoriasis-susceptibility locus PSOR1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet. 2000, 66: 1833-1844. 10.1086/302932.PubMedPubMedCentralCrossRef

22.

Gladman DD, Anhorn KA, Schachter RK, Mervat H: HLA antigens in psoriatic arthritis. J Rheumatol. 1986, 13: 586-592.PubMed

23.

Beaulieu AD, Roy R, Mathon G, Morissette J, Latulippe L, Lang JY, Mathieu JP, Brunet D, Hebert J, Archambault H: Psoriatic arthritis: risk factors for patients with psoriasis – a study based on histocompatibility antigen frequencies. J Rheumatol. 1983, 10: 633-636.PubMed

24.

Murray C, Mann DL, Gerber LN, Barth W, Perlmann S, Decker JL, Nigra TP: Histocompatibility alloantigens in psoriasis and psoriatic arthritis. Evidence for the influence of multiple genes in the major histocompatibility complex. J Clin Invest. 1980, 66: 670-675.PubMedPubMedCentralCrossRef

25.

Sakkas LI, Loqueman N, Bird H, Vaughan RW, Welsh KI, Panayi GS: HLA class II and T cell receptor gene polymorphisms in psoriatic arthritis and psoriasis. J Rheumatol. 1990, 17: 1487-1490.PubMed

26.

Espinoza LR, Vasey FB, Oh JH, Wilkinson R, Osterland CK: Association between HLA-BW38 and peripheral psoriatic arthritis. Arthritis Rheum. 1978, 21: 72-75.PubMedCrossRef

27.

Lopez-Larrea C, Torre Alonso JC, Rodriguez Perez A, Coto E: HLA antigens in psoriatic arthritis subtypes of a Spanish population. Ann Rheum Dis. 1990, 49: 318-319.PubMedPubMedCentralCrossRef

28.

Gladman DD, Farewell VT: The role of HLA antigens as indicators of disease progression in psoriatic arthritis. Arthritis Rheum. 1995, 38: 845-850.PubMedCrossRef

29.

Torre Alonso JC, Rodriguez Perez A, Arribas Castrillo JM, Ballina Garcia J, Riestra Noriega JL, Lopez Larrea C: Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients. Br J Rheumatol. 1991, 30: 245-250.PubMedCrossRef

30.

Trabace S, Cappellacci S, Ciccarone P, Liaskos S, Polito R, Zorzin L: Psoriatic arthritis: a clinical, radiological and genetic study of 58 Italian patients. Acta Derm Venereol Suppl (Stockh). 1994, 186: 69-70.

31.

Armstrong RD, Panayi GS, Welsh KI: Histocompatibility antigens in psoriasis, psoriatic arthropathy, and ankylosing spondylitis. Ann Rheum Dis. 1983, 42: 142-146.PubMedPubMedCentralCrossRef

32.

Gladman DD, Cheung C, Ng CM, Wade JA: HLA-C locus alleles in patients with psoriatic arthritis (PsA). Hum Immunol. 1999, 60: 259-261. 10.1016/S0198-8859(98)00123-2.PubMedCrossRef

33.

Gladman DD, Farewell VT, Kopciuk KA, Cook RJ: HLA markers and progression in psoriatic arthritis. J Rheumatol. 1998, 25: 730-733.PubMed

34.

O'Donnell BF, O'Loughlin S, Codd MB, Powell FC: HLA typing in Irish psoriatics. Irish Med J. 1993, 86: 65-67.

35.

Gonzalez S, Martinez-Borra J, Torre-Alonso JC, Gonzalez-Roces S, Sanchez del Rio J, Rodriguez Perez A, Brautbar C, Lopez-Larrea C: The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis. Arthritis Rheum. 1999, 42: 1010-1016. 10.1002/1529-0131(199905)42:5<1010::AID-ANR21>3.0.CO;2-H.PubMedCrossRef

36.

Gonzalez S, Brautbar C, Martinez-Borra J, Lopez-Vazquez A, Segal R, Blanco-Gelaz MA, Enk CD, Safriman C, Lopez-Larrea C: Polymorphism in MICA rather than HLA-B/C genes is associated with psoriatic arthritis in the Jewish population. Hum Immunol. 2001, 62: 632-638. 10.1016/S0198-8859(01)00242-7.PubMedCrossRef

37.

Ettehadi P, Greaves MW, Wallach D, Aderka D, Camp RD: Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions. Clin Exp Immunol. 1994, 96: 146-151.PubMedPubMedCentralCrossRef

38.

Hoehler T, Grossann S, Stradmann-Bellingghausen B, Kaluza W, Reuss E, De Vlam K, Veys E, Maerker-Hermann E: Differential association of polymorphism in the TNF-alpha region with psoriatic arthritis but not psoriasis. Arthritis Rheum. 2000, 43 (suppl): s265-

39.

Hoehler T, Kruger A, Schneider PM, Schopf RE, Knop J, Rittner C, Meyer zum Buschenfelde KH, Maerker-Hermann E: A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis. J Invest Dermatol. 1997, 109: 562-565.CrossRef

40.

Hamamoto Y, Tateno H, Ishida T, Muto M: Lack of association between promoter polymorphism of the tumor necrosis factor-alpha gene and psoriatic arthritis in Japanese patients. J Invest Dermatol. 2000, 115: 1162-1164. 10.1046/j.1523-1747.2000.0202a-5.x.PubMedCrossRef

41.

Hoehler T, Schneider PM, Rittner C, Hasenclever P, Meyer zum Buschenfelde KH, Maerker-Hermann E: LMP polymorphisms do not influence disease expression in psoriatic arthritis. Clin Exp Rheumatol. 1996, 14: 661-664.

42.

Hoehler T, Weinmann A, Schneider PM, Rittner C, Schopf RE, Knop J, Hasenclever P, Meyer zum Buschenfelde KH, Maerker-Hermann E: TAP-polymorphisms in juvenile onset psoriasis and psoriatic arthritis. Hum Immunol. 1996, 51: 49-54. 10.1016/S0198-8859(96)00156-5.CrossRef

43.

Sakkas LI, Demaine AG, Panayi GS, Welsh KI: Arthritis in patients with psoriasis is associated with an immunoglobulin gene polymorphism. Arthritis Rheum. 1988, 31: 276-278.PubMedCrossRef

44.

Sakkas LI, Marchenosi A, Kerr LA, Ranza R, Colombo B, Welsh KI, Panayi GS: Immunoglobulin heavy chain gene polymorphisms in Italian patients with psoriasis and psoriatic arthritis. Brit J Rheumatol. 1991, 30: 449-450.CrossRef

45.

Rahman P, Schentag CT, Gladman DD: Excessive paternal transmission in psoriatic arthritis. Arthritis Rheum. 1999, 42: 1228-1231. 10.1002/1529-0131(199906)42:6<1228::AID-ANR20>3.0.CO;2-3.PubMedCrossRef

46.

Wong WM, Howell WM, Coy SD, Cawley MI, Smith JL: Inter-leukin-2 is found in the synovium of psoriatic arthritis and spondyloarthritis, not in rheumatoid arthritis. Scand J Rheumatol. 1996, 25: 239-245.PubMedCrossRef

47.

Barton A, Eyre S, Myerscough A, Brintnell B, Ward D, Ollier WER, Lorentzen JC, Klareskog L, Silman A, John S, The Arthritis and Rheumatism Campaign National Repository, Worthington J: High resolution linkage and association mapping identifies a novel rheumatoid arthritis susceptibility locus homologous to one linked to two rat models of inflammatory arthritis. Hum Mol Genet. 2001, 10: 1901-1906. 10.1093/hmg/10.18.1901.PubMedCrossRef

48.

Jawaheer D, Seldin MF, Amos CI, Chen WV, Shigeta R, Monteiro J, Kern M, Criswell LA, Albani S, Nelson JL, Clegg DO, Pope R, Schroeder HW, Bridges SL, Pisetsky DS, Ward R, Kastner DL, Wilder RL, Pincus T, Callahan LF, Flemming D, Wener MH, Gregersen PK: A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoim-mune diseases. Am J Hum Genet. 2001, 68: 927-936. 10.1086/319518.PubMedPubMedCentralCrossRef

49.

Cavanaugh J: International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn's disease and chromosome 16. Am J Hum Genet. 2001, 68: 1165-1171. 10.1086/320119.PubMedCrossRef

50.

Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ: Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet. 2000, 356: 385-390. 10.1016/S0140-6736(00)02530-7.PubMedCrossRef

Titel: Genetic epidemiology: Psoriatic arthritis
Publikationsdatum: 01.06.2002
Erschienen in: Arthritis Research & Therapy / Ausgabe 4/2002
Elektronische ISSN: 1478-6362
DOI: https://doi.org/10.1186/ar415

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Chronisches Koronarsyndrom: Gefahr von Hospitalisierung wegen Herzinsuffizienz

06.05.2024 Herzinsuffizienz Nachrichten

Obwohl ein rezidivierender Herzinfarkt bei chronischem Koronarsyndrom wahrscheinlich die Hauptsorge sowohl der Patienten als auch der Ärzte ist, sind andere Ereignisse womöglich gefährlicher. Laut einer französischen Studie stellt eine Hospitalisation wegen Herzinsuffizienz eine größere Gefahr dar.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

06.05.2024 Insomnie Nachrichten

Chronische Insomnie als eigenständiges Krankheitsbild ernst nehmen und adäquat nach dem aktuellen Forschungsstand behandeln: Das forderte der Schlafmediziner Dr. Dieter Kunz von der Berliner Charité beim Praxis Update.

GLP-1-Rezeptoragonisten und SGLT-2-Hemmer: zusammen besser

06.05.2024 Typ-2-Diabetes Nachrichten

Immer häufiger wird ein Typ-2-Diabetes sowohl mit einem GLP-1-Rezeptor-Agonisten als auch mit einem SGLT-2-Inhibitor behandelt. Wie sich das verglichen mit den Einzeltherapien auf kardiovaskuläre und renale Komplikationen auswirkt, wurde anhand von Praxisdaten aus Großbritannien untersucht.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen